Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum β-Lactamases - Wikidata - thesis-toulmin - TriplyDB

Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum β-Lactamases

Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum β-Lactamases

http://www.wikidata.org/entity/Q28249617

about

Beyond Susceptible and Resistant, Part III: Treatment of Infections due to Gram-Negative Organisms Producing Carbapenemases Lethal neonatal meningoencephalitis caused by multi-drug resistant, highly virulent Escherichia coli.Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota ESBL Detection: Comparison of a Commercially Available Chromogenic Test for Third Generation Cephalosporine Resistance and Automated Susceptibility Testing in Enterobactericeae Prevalence of fecal carriage of extended-spectrum- and metallo-β-lactamase-producing gram-negative bacteria among neonates born in a hospital setting in central Saudi Arabia.

P2860

Q26747580-86C1EDA3-38AD-4586-BD76-9FAE4F3F95D1 Q30736329-58547927-3868-4832-9DD0-C2AB3073A227 Q35634838-2C9440CF-F2D5-4CD2-B436-BDFC71236762 Q36095794-2B8DE76C-D1BC-47E4-A9DC-74B9A071AADD Q41307503-A9457CD6-10F6-4000-871B-1F5FFB0EC5B8

P2860

Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum β-Lactamases

http://www.wikidata.org/entity/Q28249617

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Beyond Susceptible and Resista ...... Extended-Spectrum β-Lactamases

@ast

Beyond Susceptible and Resista ...... Extended-Spectrum β-Lactamases

@en

Beyond Susceptible and Resista ...... Extended-Spectrum β-Lactamases

@nl

type

label

Beyond Susceptible and Resista ...... Extended-Spectrum β-Lactamases

@ast

Beyond Susceptible and Resista ...... Extended-Spectrum β-Lactamases

@en

Beyond Susceptible and Resista ...... Extended-Spectrum β-Lactamases

@nl

prefLabel

Beyond Susceptible and Resista ...... Extended-Spectrum β-Lactamases

@ast

Beyond Susceptible and Resista ...... Extended-Spectrum β-Lactamases

@en

Beyond Susceptible and Resista ...... Extended-Spectrum β-Lactamases

@nl

P1433

Q28249617-DCD9D460-B21A-4B01-958A-6FB09FD024F9

P1476

Q28249617-E9F08DC4-4CFE-42A8-9B41-1C73797E42D7

P2093

Q28249617-369109F7-101C-4A16-86CF-2E8A735B6FD2

Q28249617-9382AEF1-BFD9-4C75-8673-DD57FF65FDC3

P2860

Q28249617-01680F69-F807-4118-8BDB-5AA8FEDD1FE3

Q28249617-0170AFF4-77F5-4639-BBED-D732954D6079

Q28249617-02AF6F1A-D32B-4AE3-9A51-11DDD4ADC035

Q28249617-08CBED7E-5A85-4B18-A4E4-D16297BDCD1E

Q28249617-09F9D846-7774-4B9A-ACE1-E609EC6F4028

Q28249617-0A25EF3A-DDAA-465C-9873-73662DE799DC

Q28249617-0D07E2AC-2CE7-4790-87DE-979ED7DC12E2

Q28249617-0DED1531-11A2-46A8-AF93-6BB0E3BFA153

Q28249617-0F599415-05D6-4DDC-A717-B826833E8DD8

Q28249617-112CB638-13F2-43FD-B920-1BD3A16FDC05

P304

Q28249617-7B3A0544-858C-4862-AE38-BB7DBA6A291B

P31

Q28249617-5B4FAD14-F0AC-4CAB-A01B-25AEE482C534

P3181

Q28249617-59F05912-A85F-4DB1-AFF2-5E6CE1C1F5E6

P356

Q28249617-C6F03E21-3356-4093-9BA3-E76D130934AB

P407

Q28249617-64ED0042-309B-486A-8CEC-B418DBFD908D

P433

Q28249617-BA8FDE8D-8AF9-499A-A600-7AE21752F57C

P478

Q28249617-E6E3DB9C-C934-4D4E-9E9A-ACF94E94549B

P577

Q28249617-19FCE18E-86F7-403B-B22E-2E4966C687B3

P698

Q28249617-E9B6A557-8024-4A98-B658-6EE1C6A7ECE7

P921

Q28249617-6EF39FFB-5702-406D-A6C6-B622E0ABC72E

P932

Q28249617-318F8345-9BDE-4669-BA59-BACD8B4F94D6

P3181

P356

1551-6776-19.3.156

P1433

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

P1476

Beyond Susceptible and Resista ...... Extended-Spectrum β-Lactamases

@en

P2093

Conan MacDougall

http://www.w3.org/2001/XMLSchema#string

Jennifer Curello

http://www.w3.org/2001/XMLSchema#string

P2860

Extended-spectrum beta-lactamases: a clinical update

beta-Lactamases in laboratory and clinical resistance

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis

Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004).

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula.

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in French children

Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints.

P304

156-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4109309

http://www.w3.org/2001/XMLSchema#string

P356

10.5863/1551-6776-19.3.156

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25309145

http://www.w3.org/2001/XMLSchema#string

P921

Gram-negative bacteria

P932

4187532

http://www.w3.org/2001/XMLSchema#string